Anzeige
Mehr »
Login
Dienstag, 15.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Global Tactical tritt dem Critical Minerals Institute bei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 29.03.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
29.03.Mineralys Therapeutics, Inc.: Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology's ...155- Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted reduction (p=0.001), assessed by 24hr ABPM at week 12, with favorable safety and tolerability profile...
► Artikel lesen
29.03.Novo Nordisk A/S: Rybelsus (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 20251.036Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial1.Data...
► Artikel lesen
29.03.Novo Nordisk A/S: Ozempic (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025862Ozempic® improved maximum walking distance by 13% vs placebo in adults with type 2 diabetes and peripheral artery disease (PAD) in the phase 3 STRIDE trial1.Data were presented at the American College...
► Artikel lesen
29.03.Helios Fairfax Partners Corporation: Financial Results for the Fourth Quarter of 20241.152NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced...
► Artikel lesen
29.03.Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results325SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (Nasdaq: TSBX), a biotechnology company historically focused on the development of a differentiated...
► Artikel lesen
29.03.Osisko Development Corp.: Osisko Development Reports Fourth Quarter and Year-End 2024 Results407(All dollar amounts are expressed in Canadian dollars, unless stated otherwise) MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or...
► Artikel lesen
29.03.Partners Value Split Corp. Announces 2024 Annual Results1.555TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Partners Value Split Corp. (the "Company", TSX: PVS.PR.G, PVS.PR.H, PVS.PR.I, PVS.PR.J, PVS.PR.K, PVS.PR.L) announced today that the net asset value per...
► Artikel lesen
29.03.HYTN Innovations Inc.: HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market583VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing...
► Artikel lesen
29.03.Summit State Bank Reports Revised Fourth Quarter 2024 Financial Results265SANTA ROSA, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- Summit State Bank (the "Bank") (Nasdaq: SSBI) today reported that it has revised its fourth quarter and full year 2024 financial results from...
► Artikel lesen
29.03.Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates501SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to...
► Artikel lesen